Ocular melanoma

Cutis

Volumn 63, Issue 5, 1999, Pages 285-292

  Cather, J Christian ^a   Cather, Jennifer Clay ^b   Soparkar, Charles N ^d   Nelson, Bruce R ^b,c,e  

^a Houston Eye Associates   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d Plastic Eye Surgery Associates   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EYE; EYE TUMOR; HISTOLOGY; HUMAN; LIVER TUMOR; MELANOMA; METASTASIS; PATHOLOGY; PROGNOSIS; REVIEW;

EYE; EYE NEOPLASMS; HUMANS; LIVER NEOPLASMS; MELANOMA; PROGNOSIS;

EID: 0033124450     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. McCartney A: Pathology of ocular melanoma. Br Med Bull 51: 678-693, 1995.
2. Koh HK: Cutaneous melanoma. N Engl J Med 325: 171-182, 1991.
3. Grin JM, Grant-Kels JM, Grin CM, et al: Ocular melanomas and melanocytic lesions of the eye. J Am Acad Dermatol 38: 716-730, 1998.
4. Egan KM, Seddon JM, Glynn RJ, et al: Epidemiologic aspects of uveal melanoma. Surv Ophthalmol 32: 239-251, 1988.
5. Hungerford JL: Management of ocular melanoma. Br Med Bull 63(9): 729-731, 1995.
6. Stanford DG, Hart R, Thompson JF: Ocular melanoma in childhood. Aust N Z J Surg 63: 729-731, 1993.
7. Singh AD, Wang MX, Donoso LA, et al: Genetic aspects of uveal melanoma: a brief review. Semin Oncol 23: 768-772, 1996.
8. Singh AD, Shields CL, De Potter P, et al: Familial uveal melanoma: clinical observations in 56 patients. Arch Ophthalmol 114: 392-399, 1996.
9. Singh AD, Wang MX, Donoso LA, et al: Familial uveal melanoma, III. Arch Ophthalmol 114: 1101-1104, 1996.
10. Holly EA, Aston DA, Char DH, et al: Uveal melanomas in relation to ultraviolet light exposure and host factors. Cancer Res 50: 5773-5777, 1990.
11. Gonder JR, Shields JA, Albert DM, et al: Uveal malignant melanoma associated with ocular and oculodermal melanocytosis. Ophthalmology 89: 953-960, 1989.
12. Gonder JR, Ezell PC, Shields JA, et al: Ocular melanocytosis. A study to determine the prevalence rate of ocular melanocytosis. Ophthalmology 89: 950-952, 1982.
13. Patel BC, Egan CA, Lucius RW, et al: Cutaneous malignant melanoma and oculodermal melanocytosis (nevus of Ota): report of a case and review of the literature. J Am Acad Dermatol 38(5): 862-865, 1998.
14. Frezzotti R, Guerra R, Dragoni GB, et al: Malignant melanoma of the choroid in a case of naevus of Ota. Br J Ophthalmol 52: 922-924, 1968.
15. Tyndel FJ, Davidson GS, Bilbao JM: Nevus of Ota (comment). Neurology 44(3): 583, 1994.
16. Balmaceda CM, Fetell MR, O'Brien JL, et al: Nevus of Ota and leptomeningeal melanocytic lesions. Neurology 43(2): 381-386, 1993.
17. Specht CS, Smith TW: Uveal malignant melanoma and von Recklinghausen's neurofibromatosis. Cancer 62: 812-817, 1988.
18. Singh AD, Shields CL, Shields JA, et al: Uveal melanoma and familial atypical mole and melanoma (FAM-M) syndrome. Ophthal Genet 16: 53-61, 1995.
19. Morgan SS, Heidenry R, Bowen SF: Malignant melanoma of iris and ciliary body occurring as a third primary malignancy. Am J Ophthal 76: 26-29, 1973.
20. Callender GR: Malignant melanotic tumors of the eye. A study of histologic types in 111 cases. Trans Am Acad Ophthalmol Otolarngology 1667: 225-228, 1931.
21. Davidorf FH, Lang JR: The natural history of melanoma of the choroid: small versus large tumors. Ophthalmology 79: 310-320, 1975.
22. Territo C, Shields CL, Shields JA, et al: Natural course of melanocytic tumors of the iris. Ophthalmology 95: 1251-1255, 1988.
23. Grossniklaus HE, Wilson MW, Barron BC, et al: Anterior vs. posterior intraocular melanoma. Arch Ophthalmol 114: 1116-1120, 1996.
24. Shields JA, Shields CL: Current management of posterior uveal melanoma. Mayo Clin Proc 68: 1196-1200, 1993.
25. McLean W: Prognostic factors for uveal malignant melanoma. Ophthalmol Clin North Am 8: 143-153, 1995.
26. Scotto J, Fraumeni JF, Lee JAH: Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J Natl Cancer Inst 56: 489-491, 1976.
27. Ganley JP, Comstock GW: Benign nevi and malignant melanomas in the choroid. Am J Ophthalmol 76: 19-25, 1973.
28. Font RL, Spaulding AG, Zimmerman LE: Diffuse malignant melanoma of the uveal tract: a clinicopathologic report of 54 cases. Trans Am Acad Ophthalmol Otolaryngol 72: 877-895, 1968.
29. Shields CL, Shields JA, DePotter P, et al: Diffuse choroidal melanoma. Arch Ophthalmol 114: 956-963, 1996.
30. Shields GL, Shields JA, Kiratli H, et al: Risk factors for growth and metastasis of small choroidal melanocytic lesions. Ophthalmol 102(9): 1351-1361, 1995.
31. Augsburger JJ, Gamel JW, Shields JA, et al: Post-irradiation regression of choroidal melanoma as a risk factor for death from metastatic disease. Ophthalmology 94: 1173-1177, 1987.
32. Ackerman AB: Response to Dr. Folberg et al: primary acquired melanosis of the conjunctiva is melanoma in situ. Mod Pathol 5: 6-8, 1991.
33. Ackerman AB, Sood, Koenig M: Primary acquired melanosis of the conjunctiva equivalent to melanoma in situ? Mod Pathol 4: 253-263, 1991.
34. Jakobiec FA, Folberg R, Iwamoto T: Clinicopathologic characteristics of premalignant and malignant melanocytic lesions of the conjunctiva. Ophthalmology 96: 147-166, 1989.
35. Folberg R, McLean IW, Zimmerman LE: Conjunctival melanosis and melanoma. Ophthalmology 91: 673-678, 1984.
36. Folberg R, McLean IW, Zimmerman LE: Malignant melanoma of the conjunctiva. Hum Pathol 16: 136-143, 1985.
37. Folberg R, McLean IW, Zimmerman LE: Primary acquired melanosis of the conjunctiva. Hum Pathol 16: 129-135, 1985.
38. Buckman G, Jakobiec FA, Folberg R, et al: Melanocytic nevi of the palpebral conjunctiva: an extremely rare location usually signifying melanoma. Ophthalmology 95: 1053-1057, 1988.
39. Farber M, Schutzer, Mihm MC: Pigmented lesions of the conjunctiva. J Am Acad Dermatol 38: 971-978, 1998.
40. Liesegang TJ: Pigmented conjunctival and scleral lesions, symposium on ocular tumors. Part V. Mayo Clin Proc 69: 151-161, 1994.
41. Paridaens ADA, Minassian DC, McCartney ACE, et al: Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathologic study of 256 cases. Br J Ophthalmol 78: 252-259, 1994.
42. Finger PT, Milner MS, McCormick SA: Topical chemotherapy for conjunctival melanoma. Br J Ophthalmol 77(11): 751, 1993.
43. Finger PT, Czechonska G, Liarikos S: Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia. Br J Ophthalmol 82: 476-479, 1998.